0501-1.0mg · Anti-Olanzapine (Clone OLA-9251) - 1.0 mg

Olanzapine, a second-generation or atypical antipsychotic, is widely used in the
management of various mental health disorders, including schizophrenia and bipolar
disorder. Introduced in the late 20th century, olanzapine exerts its therapeutic effects by
antagonizing multiple neurotransmitter receptors, particularly dopamine and serotonin
receptors in the brain. This dual-action helps to modulate the imbalances in these
neurotransmitters associated with psychotic disorders. Olanzapine's method of action
also involves histamine and alpha-adrenergic receptors blockade, contributing to its
efficacy and potential side effects. Diagnostic testing for olanzapine is not standard
practice, but periodic monitoring may be considered in specific cases for therapeutic
drug monitoring. Blood tests can be utilized to measure olanzapine levels, aiding
clinicians in optimizing dosage to achieve optimal symptom control while minimizing
adverse effects. This tailored approach to monitoring ensures a personalized and
effective treatment strategy for individuals prescribed olanzapine for various psychiatric
conditions.

- Product categories: Primary Monoclonal Antibodies
- Pkg Size: 1.0 mg
- Clone: OLA-9251
- Target: Olanzapine
- Research Area: Matched Pair, IVD Raw Material, Psychiatric
- Applications: ELISA, Lateral Flow
- Concentration: ≥1.0 mg/ml
- Formulation: Formulated in 0.015M potassium phosphate buffered saline (0.85%), pH 7.2 and contains 0.05% sodium azide.
- Storage and Stability: This purified antibody is stable when stored at 2-8°C. Do not freeze.